Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 3/2005

01-07-2005

Cryptogenic organizing pneumonia after radiotherapy for breast cancer

Authors: Kenji Akita, Aiko Ikawa, Shigeki Shimizu, Kazuya Tsuboi, Kazuhiro Ishihara, Shigeki Sato, Ryuzo Ueda

Published in: Breast Cancer | Issue 3/2005

Login to get access
Metadata
Title
Cryptogenic organizing pneumonia after radiotherapy for breast cancer
Authors
Kenji Akita
Aiko Ikawa
Shigeki Shimizu
Kazuya Tsuboi
Kazuhiro Ishihara
Shigeki Sato
Ryuzo Ueda
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 3/2005
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.2325/jbcs.12.243

Other articles of this Issue 3/2005

Breast Cancer 3/2005 Go to the issue

OriginalPaper

Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a bayesian approach

OriginalPaper

Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer

Report

A case of burkitt’s lymphoma involving both breasts

OriginalPaper

Prediction of early and late recurrence in patients with breast carcinoma

OriginalPaper

Ultrasound demonstration of mammographically detected microcalcifications in patients with ductal carcinomain situ of the breast

OriginalPaper

Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution following high dose chemotherapy in patients with breast cancer: results of a feasibility study in Japan
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits